Showing results (41-50 of 406) with videos related to
Sort By:
Pageof 41
Rheumatology (Oxford, England)|July 4, 2012
Improvements in health-related quality of life after treatment with tocilizumab in patients with rheumatoid arthritis refractory to tumour necrosis factor inhibitors: results from the 24-week randomized controlled RADIATE studyVibeke Strand, Gerd R Burmester, Sarika Ogale, et al.Arthritis and Rheumatism|September 30, 2008
Reactivation of rheumatoid arthritis after pregnancy: increased phagocyte and recurring lymphocyte gene activityThomas Häupl, Monika Østensen, Andreas Grützkau, et al.Rheumatology (Oxford, England)|April 19, 2021
Long-term safety and efficacy of sarilumab over 5 years in patients with rheumatoid arthritis refractory to TNF inhibitorsRoy Fleischmann, Mark C Genovese, Karina Maslova, et al.BMJ Open|March 2, 2018
Design of a phase IV randomised, double-blind, placebo-controlled trial assessing the ImPact of Residual Inflammation Detected via Imaging TEchniques, Drug Levels and Patient Characteristics on the Outcome of Dose TaperIng of Adalimumab in Clinical Remission Rheumatoid ArThritis (RA) patients (PREDICTRA)Paul Emery, Gerd R Burmester, Esperanza Naredo, et al.Annals of the Rheumatic Diseases|May 15, 2017
High maternal expression of SIGLEC1 on monocytes as a surrogate marker of a type I interferon signature is a risk factor for the development of autoimmune congenital heart blockAnna R Lisney, Franziska Szelinski, Karin Reiter, et al.Annals of the Rheumatic Diseases|May 27, 2011
Mavrilimumab, a human monoclonal antibody targeting GM-CSF receptor-α, in subjects with rheumatoid arthritis: a randomised, double-blind, placebo-controlled, phase I, first-in-human studyGerd R Burmester, Eugen Feist, Matthew A Sleeman, et al.Arthritis Research & Therapy|April 25, 2007
Treatment of posttraumatic and focal osteoarthritic cartilage defects of the knee with autologous polymer-based three-dimensional chondrocyte grafts: 2-year clinical resultsChristian Ossendorf, Christian Kaps, Peter C Kreuz, et al.Clinical Rheumatology|May 20, 2023
Effect of nintedanib in patients with progressive pulmonary fibrosis associated with rheumatoid arthritis: data from the INBUILD trialEric L Matteson, Martin Aringer, Gerd R Burmester, et al.Expert Opinion on Pharmacotherapy|June 7, 2005
Leflunomide: long-term clinical experience and new usesJ Peter Kaltwasser, Frank BehrensJournal of Clinical Medicine|December 23, 2022
Effectiveness of Different Rituximab Doses Combined with Leflunomide in the Treatment or Retreatment of Rheumatoid Arthritis: Part 2 of a Randomized, Placebo-Controlled, Investigator-Initiated Clinical Trial (AMARA)Michaela Koehm, Ann C Foldenauer, Tanja Rossmanith, et al.Pageof 41